Medical Injection Molding Market Report 2026

Medical Injection Molding Market Overview

• Medical Injection Molding market size has reached to $27.32 billion in 2025 • Expected to grow to $38.32 billion in 2030 at a compound annual growth rate (CAGR) of 6.8% • Growth Driver: Rising Demand For Medical Equipment Fuels Growth In Medical Injection Molding • Market Trend: Innovative All-Electric Injection Molding Machines Enhance Cleanroom Manufacturing For Medical Components • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Medical Injection Molding Market?

Medical injection molding is a manufacturing process used to produce precise, high-quality plastic components for medical devices and equipment by injecting molten plastic into a mold. It is utilized to create various medical products, such as syringes, surgical instruments, and implantable devices, ensuring consistency and sterility in mass production. The main products of medical injection molding are medical equipment components, consumables, patient aids, orthopedic instruments, and dental products. Medical equipment components refer to specialized parts and components utilized in medical devices, such as diagnostic equipment, imaging machines, and surgical tools. The various materials include plastic, metal, ceramic, and others in different classes of devices, such as class I, class II, and class III. A variety of applications include medical devices, diagnostic instruments, surgical instruments, and pharmaceutical delivery, used by hospitals, clinics, diagnostic centers, and pharmaceutical companies.

What Is The Medical Injection Molding Market Growth Forecast?

The medical injection molding market size is expected to see strong growth in the next few years. It will grow to $38.32 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for advanced medical devices, increasing focus on cost-efficient mass production, expanding pharmaceutical and drug delivery markets, growing adoption of minimally invasive procedures, rising regulatory emphasis on product consistency and quality. Major trends in the forecast period include growing demand for high-precision plastic components in medical devices, increasing adoption of injection-molded disposable medical consumables, rising use of medical injection molding for complex and miniaturized parts, expansion of injection molding applications in pharmaceutical delivery devices, growing preference for scalable and high-volume medical manufacturing.

Global Medical Injection Molding Market Segmentation

1) By Product: Medical Equipment Components, Consumables 2) By Classes: Class I, Class II, Class III 3) By Application: Medical Devices, Diagnostic Instruments, Pharmaceutical Delivery Subsegments: 1) By Medical Equipment Components: Surgical Instrument Handles, Catheters And Tubing Components, Infusion Sets And Syringe Components, Respiratory Device Components 2) By Consumables: IV Components, Inhalers And Nebulizers

What Is The Driver Of The Medical Injection Molding Market?

The rising demand for medical equipment is expected to propel the medical injection molding market going forward. Medical equipment refers to devices, instruments, machines, or implants used in healthcare to diagnose, treat, monitor, or prevent medical conditions. The medical equipment gained traction due to the increasing prevalence of chronic diseases, the expansion of healthcare infrastructure, and the need for medical device infrastructure updates. Medical injection molding facilitates the efficient and precise production of complex medical device components for various applications within the healthcare industry. This manufacturing process is essential for producing high-quality, reliable parts that meet stringent medical standards. For instance, in July 2024, according to the American Hospital Association, a US-based non-profit hospital association, the United States had imported $14.9 billion in medical equipment as of May 2, 2024, compared with $14 billion at the same point in 2023, highlighting a clear year-on-year increase in equipment flows to support patient care. Therefore, the rising demand for medical equipment is driving the growth of the medical injection molding industry.

Key Players In The Global Medical Injection Molding Market

Major companies operating in the medical injection molding market are Jabil Inc., Flex Ltd., Gerresheimer AG, Viant Medical Inc., Nolato AB, Westfall Technik Inc., Biomerics, Mack Group, Proto Labs, Cadence Inc., Baytech Plastics Inc., C&J Industries, HTI Plastics, Currier Plastics Inc., The Rodon Group, H&K Müller GmbH & Co. KG, Donatelle Plastics, Harbec, All-Plastics, Bright Plastics, D&M Plastics LLC, JG Plastics Group LLC

Global Medical Injection Molding Market Trends and Insights

Major companies operating in the medical injection molding market are increasing their focus on electric injection molding machines designed for cleanroom environments. Electric injection molding machines designed for cleanroom environments manufacture precise, contamination-free medical components and devices with stringent quality and hygiene requirements. For instance, in March 2024, Shibaura Machine Company, a Japan-based company that provides precision injection molding machines, machine tools, and die-casting machines, launched the EC110SXIII machine to mold various products. This features an all-electric design with plated platens, stainless steel guarding, a raised platform for easy cleaning, NFS H1-certified lubrication grease, an extended ejector stroke, and a cleanroom-specific design. These technological advancements ensure improved cleanliness, precision, efficiency, durability, and versatility while meeting stringent medical standards, enhancing its significance in the medical injection molding market for producing precise and contamination-free medical components in regulated cleanroom environments.

What Are Latest Mergers And Acquisitions In The Medical Injection Molding Market?

In August 2023, DuPont, a US-based company providing technology-based materials and solutions, acquired Spectrum Plastics Group for $1.75 billion. This acquisition enhances DuPont's global presence and product portfolio in the medical device industry while significantly bolstering medical injection molding capabilities, strengthening competitiveness, and fostering new growth opportunities in this specialized market segment. Spectrum Plastics Group is a Georgia-based company operating as a precision injection molder of advanced thermoplastics.

Regional Outlook

Asia-Pacific was the largest region in the medical injection molding market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Medical Injection Molding Market?

The medical injection molding market consists of sales of custom implants, laboratory equipment housings, catheters, medical tubing, ophthalmic devices, and enclosures for electronic health monitoring devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.